1-6 of 6
Pankaj Bhargava
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia

Alexey V. Danilov, Charles Herbaux, Harriet S. Walter, Peter Hillmen, Simon A. Rule, Ebenezer A. Kio, Lionel Karlin, Martin J.S. Dyer, Siddhartha S. Mitra, Ping Cheng Yi, Rita Humeniuk, Xi Huang, Ziqian Zhou, Pankaj Bhargava, Juliane M. Jürgensmeier, Christopher D. Fegan
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (12): 2810–2818.
https://doi.org/10.1158/1078-0432.CCR-19-3504
Published: 15 June 2020
View article titled, Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia
Open the PDF for Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia in another window
Includes: Supplementary data
Journal Articles

Population-based engineered tumor models as a platform for biomarker discovery in cancer

Feng Jiang, Jie Lin, Xiaojian Sun, Bin Feng, Richard Nicoletti, Guangmu Li, M. Isabel Chiu, Brooke Esteves, Mohammed Al-Adhami, Pankaj Bhargava, Murray O. Robinson
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19_Supplement): B10.
https://doi.org/10.1158/DIAG-10-B10
Published: 15 August 2014
View article titled, Population-based engineered tumor models as a platform for biomarker discovery in cancer
Journal Articles

Efficacy, Safety, Pharmacokinetics, and Biomarkers of Cediranib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

Andrew X. Zhu, Marek Ancukiewicz, Jeffrey G. Supko, Dushyant V. Sahani, Lawrence S. Blaszkowsky, Jeffrey A. Meyerhardt, Thomas A. Abrams, Nadine Jackson McCleary, Pankaj Bhargava, Alona Muzikansky, Susan Sheehan, Eileen Regan, Eamala Vasudev, Michelle Knowles, Charles S. Fuchs, David P. Ryan, Rakesh K. Jain, Dan G. Duda
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (6): 1557–1566.
https://doi.org/10.1158/1078-0432.CCR-12-3041
Published: 14 March 2013
View article titled, Efficacy, Safety, Pharmacokinetics, and Biomarkers of Cediranib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
Open the PDF for Efficacy, Safety, Pharmacokinetics, and Biomarkers of Cediranib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study in another window
Includes: Supplementary data
Journal Articles

Biologic and Clinical Activity of Tivozanib (AV-951, KRN-951), a Selective Inhibitor of VEGF Receptor-1, -2, and -3 Tyrosine Kinases, in a 4-Week-On, 2-Week-Off Schedule in Patients with Advanced Solid Tumors

Ferry A.L.M. Eskens, Maja J.A. de Jonge, Pankaj Bhargava, Toshiyuki Isoe, Monette M. Cotreau, Brooke Esteves, Kunihiko Hayashi, Herman Burger, Maarten Thomeer, Leni van Doorn, Jaap Verweij
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (22): 7156–7163.
https://doi.org/10.1158/1078-0432.CCR-11-0411
Published: 14 November 2011
View article titled, Biologic and Clinical Activity of Tivozanib (AV-951, KRN-951), a Selective Inhibitor of VEGF Receptor-1, -2, and -3 Tyrosine Kinases, in a 4-Week-On, 2-Week-Off Schedule in Patients with Advanced Solid Tumors
Open the PDF for Biologic and Clinical Activity of Tivozanib (AV-951, KRN-951), a Selective Inhibitor of VEGF Receptor-1, -2, and -3 Tyrosine Kinases, in a 4-Week-On, 2-Week-Off Schedule in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

A Phase I and Pharmacokinetic Study of Squalamine, a Novel Antiangiogenic Agent, in Patients with Advanced Cancers

Pankaj Bhargava, John L. Marshall, William Dahut, Naiyer Rizvi, Nina Trocky, Jon I. Williams, Howard Hait, Sharon Song, Kenneth J. Holroyd, Michael J. Hawkins
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (12): 3912–3919.
Published: 01 December 2001
View article titled, A Phase I and Pharmacokinetic Study of Squalamine, a Novel Antiangiogenic Agent, in Patients with Advanced Cancers
Open the PDF for A Phase I and Pharmacokinetic Study of Squalamine, a Novel Antiangiogenic Agent, in Patients with Advanced Cancers in another window
Journal Articles

A Phase I and Pharmacokinetic Study of TNP-470 Administered Weekly to Patients with Advanced Cancer

Pankaj Bhargava, John L. Marshall, Naiyer Rizvi, William Dahut, Joseph Yoe, Manuela Figuera, Kim Phipps, Voon S. Ong, Allen Kato, Michael J. Hawkins
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (8): 1989–1995.
Published: 01 August 1999
View article titled, A Phase I and Pharmacokinetic Study of TNP-470 Administered Weekly to Patients with Advanced Cancer
Open the PDF for A Phase I and Pharmacokinetic Study of TNP-470 Administered Weekly to Patients with Advanced Cancer in another window